Serge Belanger
Stock Analyst at Needham
(3.49)
# 775
Out of 4,810 analysts
333
Total ratings
42.12%
Success rate
4.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRTX Heron Therapeutics | Reiterates: Buy | $4 | $1.92 | +108.33% | 22 | Apr 11, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $15 | $7.40 | +102.70% | 12 | Apr 10, 2025 | |
| LQDA Liquidia | Reiterates: Buy | $25 | $13.60 | +83.82% | 28 | Apr 10, 2025 | |
| AMPH Amphastar Pharmaceuticals | Reiterates: Hold | n/a | $23.50 | - | 5 | Apr 10, 2025 | |
| COLL Collegium Pharmaceutical | Reiterates: Buy | $46 | $27.12 | +69.62% | 25 | Apr 9, 2025 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $20 | $13.19 | +51.63% | 20 | Apr 9, 2025 | |
| VRCA Verrica Pharmaceuticals | Reiterates: Hold | n/a | $0.49 | - | 18 | Apr 9, 2025 | |
| EOLS Evolus | Reiterates: Buy | $22 | $10.23 | +115.05% | 14 | Apr 9, 2025 | |
| CRMD CorMedix | Reiterates: Buy | $12 | $7.40 | +62.16% | 16 | Apr 9, 2025 | |
| CLSD Clearside Biomedical | Reiterates: Buy | $4 | $0.82 | +386.74% | 14 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $16.06 | +161.52% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $24.88 | +28.62% | 27 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $6.20 | +287.10% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $38.56 | +86.72% | 21 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.00 | +402.16% | 18 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $11.95 | +134.31% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.53 | +99.20% | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.87 | - | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $66 | $36.77 | +79.49% | 11 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $12.80 | +196.88% | 15 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $33.03 | +81.65% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.89 | - | 1 | Mar 31, 2022 |
Heron Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $4
Current: $1.92
Upside: +108.33%
BioCryst Pharmaceuticals
Apr 10, 2025
Reiterates: Buy
Price Target: $15
Current: $7.40
Upside: +102.70%
Liquidia
Apr 10, 2025
Reiterates: Buy
Price Target: $25
Current: $13.60
Upside: +83.82%
Amphastar Pharmaceuticals
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $23.50
Upside: -
Collegium Pharmaceutical
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $27.12
Upside: +69.62%
Arcutis Biotherapeutics
Apr 9, 2025
Reiterates: Buy
Price Target: $20
Current: $13.19
Upside: +51.63%
Verrica Pharmaceuticals
Apr 9, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.49
Upside: -
Evolus
Apr 9, 2025
Reiterates: Buy
Price Target: $22
Current: $10.23
Upside: +115.05%
CorMedix
Apr 9, 2025
Reiterates: Buy
Price Target: $12
Current: $7.40
Upside: +62.16%
Clearside Biomedical
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $0.82
Upside: +386.74%
Apr 8, 2025
Reiterates: Buy
Price Target: $42
Current: $16.06
Upside: +161.52%
Apr 8, 2025
Reiterates: Buy
Price Target: $32
Current: $24.88
Upside: +28.62%
Apr 8, 2025
Reiterates: Buy
Price Target: $24
Current: $6.20
Upside: +287.10%
Apr 8, 2025
Reiterates: Buy
Price Target: $72
Current: $38.56
Upside: +86.72%
Apr 8, 2025
Reiterates: Buy
Price Target: $5
Current: $1.00
Upside: +402.16%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $11.95
Upside: +134.31%
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $7.53
Upside: +99.20%
Apr 1, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.87
Upside: -
Feb 27, 2025
Maintains: Buy
Price Target: $62 → $66
Current: $36.77
Upside: +79.49%
Jan 7, 2025
Reiterates: Buy
Price Target: $38
Current: $12.80
Upside: +196.88%
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $33.03
Upside: +81.65%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.89
Upside: -